Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Int J Mol Sci. 2024 Nov 1;25(21):11759. doi: 10.3390/ijms252111759.
COVID-19, caused by SARS-CoV-2, triggers a complex immune response, with T regulatory cells (Tregs) playing a crucial role in maintaining immune homeostasis and preventing excessive inflammation. The current study investigates the function of T regulatory cells during COVID-19 infection and the subsequent recovery period, emphasizing their impact on immune regulation and inflammation control. We conducted a comprehensive analysis of Treg subpopulations in peripheral blood samples from COVID-19 patients at different stages: acute infection, early convalescence, and long-term recovery. Flow cytometry was employed to quantify Tregs including "naïve", central memory (CM), effector memory (EM), and terminally differentiated CD45RA effector cells (TEMRA). Additionally, the functional state of the Tregs was assessed by the expression of purinergic signaling molecules (CD39, CD73). Cytokine profiles were assessed through multiplex analysis. Our findings indicate a significant decrease in the number of Tregs during the acute phase of COVID-19, which correlates with heightened inflammatory markers and increased disease severity. Specifically, we found a decrease in the relative numbers of "naïve" and an increase in EM Tregs, as well as a decrease in the absolute numbers of "naïve" and CM Tregs. During the early convalescent period, the absolute counts of all Treg populations tended to increase, accompanied by a reduction in pro-inflammatory cytokines. Despite this, one year after recovery, the decreased subpopulations of regulatory T cells had not yet reached the levels observed in healthy donors. Finally, we observed the re-establishment of CD39 expression in all Treg subsets; however, there was no change in CD73 expression among Tregs. Understanding these immunological changes across different T regulatory subsets and adenosine signaling pathways offers important insights into the disease's pathogenesis and provides a broader view of immune system dynamics during recovery.
新型冠状病毒病(COVID-19)由严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)引起,可引发复杂的免疫反应,调节性 T 细胞(Treg)在维持免疫平衡和防止过度炎症中发挥关键作用。本研究旨在探讨 Treg 在 COVID-19 感染及后续恢复期的功能,强调其对免疫调节和炎症控制的影响。我们对不同阶段 COVID-19 患者外周血样本中的 Treg 亚群进行了全面分析,包括急性感染期、早期恢复期和长期恢复期。采用流式细胞术检测 Treg 亚群,包括“幼稚”、中央记忆(CM)、效应记忆(EM)和终末分化 CD45RA 效应细胞(TEMRA)。此外,通过嘌呤能信号分子(CD39、CD73)的表达评估 Treg 的功能状态。通过多重分析评估细胞因子谱。研究结果表明,COVID-19 急性期中 Treg 数量显著减少,与炎症标志物升高和疾病严重程度增加相关。具体而言,我们发现“幼稚”Treg 的相对数量减少,EM Treg 的相对数量增加,“幼稚”和 CM Treg 的绝对数量减少。在早期恢复期,所有 Treg 群体的绝对计数均有增加,同时促炎细胞因子减少。尽管如此,一年后恢复期,调节性 T 细胞的减少亚群尚未恢复到健康供者的水平。最后,我们观察到所有 Treg 亚群中 CD39 的表达重新建立;然而,Treg 中 CD73 的表达没有变化。了解不同 Treg 亚群和腺苷信号通路中的这些免疫变化,为疾病发病机制提供了重要见解,并为恢复期免疫系统动态提供了更广泛的视角。